Cargando…
Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction
Autores principales: | Vaira, Luigi Angelo, Lechien, Jerome R., Dore, Stefano, Boccaletti, Riccardo, Saussez, Sven, De Riu, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380412/ https://www.ncbi.nlm.nih.gov/pubmed/34458129 http://dx.doi.org/10.1007/s12070-021-02818-z |
Ejemplares similares
-
The Trajectories of Olfactory Dysfunction from the First to the Omicron Wave: Are We Getting over it?
por: Vaira, Luigi Angelo, et al.
Publicado: (2022) -
In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Vaira, Luigi Angelo, et al.
Publicado: (2022) -
Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic
por: Saussez, Sven, et al.
Publicado: (2023) -
Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study
por: Lechien, Jerome R., et al.
Publicado: (2022) -
Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load?
por: Vaira, Luigi Angelo, et al.
Publicado: (2021)